Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
出版年份 2022 全文链接
标题
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
作者
关键词
-
出版物
NATURE MEDICINE
Volume 28, Issue 9, Pages 1872-1882
出版商
Springer Science and Business Media LLC
发表日期
2022-08-30
DOI
10.1038/s41591-022-01916-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A critical role for fas-mediated off-target tumor killing in T cell immunotherapy
- (2021) Ranjan Upadhyay et al. Cancer Discovery
- Tumor interferon signaling and suppressive myeloid cells associate with CAR T cell failure in large B cell lymphoma
- (2021) Michael D. Jain et al. BLOOD
- Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma
- (2021) Wenying Liu et al. Experimental and Therapeutic Medicine
- The Next Decade of Immune Checkpoint Therapy
- (2021) Padmanee Sharma et al. Cancer Discovery
- CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
- (2021) Vicki Plaks et al. BLOOD
- Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer
- (2021) Ayumi Hashimoto et al. CLINICAL CANCER RESEARCH
- SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells
- (2021) Suhong Xia et al. Cell Death & Disease
- LAG-3 Expression Predicts Outcome in Stage II Colon Cancer
- (2021) Gaëlle Rhyner Agocs et al. Journal of Personalized Medicine
- Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
- (2021) Frederick L. Locke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
- (2020) Cassie K. Chou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
- (2020) Matias Autio et al. HAEMATOLOGICA
- Tumor Immunology and Tumor Evolution: Intertwined Histories
- (2020) Jérôme Galon et al. IMMUNITY
- Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
- (2020) Jennifer N. Brudno et al. NATURE MEDICINE
- High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations
- (2020) Lorena Maestre et al. PLoS One
- Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction
- (2020) Nathan Singh et al. Cancer Discovery
- Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer
- (2020) Florence Marliot et al. Journal for ImmunoTherapy of Cancer
- Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel
- (2020) Rawan Faramand et al. CLINICAL CANCER RESEARCH
- Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy
- (2020) Pei-Hsuan Chen et al. JCI Insight
- All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy
- (2020) Evripidis Lanitis et al. CURRENT OPINION IN BIOTECHNOLOGY
- Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
- (2020) Kathryn M. Cappell et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
- (2020) Frederick L. Locke et al. Blood Advances
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Diffuse Large B cell Lymphoma: 2019 update on diagnosis, risk-stratification and treatment
- (2019) Yang Liu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
- (2019) Davide Bedognetti et al. Journal for ImmunoTherapy of Cancer
- Immune evasion before tumour invasion in early lung squamous carcinogenesis
- (2019) Céline Mascaux et al. NATURE
- TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
- (2019) Omar Khan et al. NATURE
- The Pivotal Role of Regulatory T Cells in the Regulation of Innate Immune Cells
- (2019) Emeka B. Okeke et al. Frontiers in Immunology
- Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients
- (2019) Jingping Yuan et al. Cancer Cell International
- The Immunoscore: Colon Cancer and Beyond
- (2019) Helen K Angell et al. CLINICAL CANCER RESEARCH
- PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia
- (2019) Kazuki Okuyama et al. PLoS Genetics
- Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism
- (2019) Clarissa Campbell et al. Cell Metabolism
- Cytokines in the Treatment of Cancer
- (2018) Kevin C. Conlon et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis
- (2018) Matt Teater et al. Nature Communications
- The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells
- (2018) Takato Yomoda et al. ANNALS OF SURGICAL ONCOLOGY
- The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
- (2018) Marc Van den Eynde et al. CANCER CELL
- Evolution of Metastases in Space and Time under Immune Selection
- (2018) Mihaela Angelova et al. CELL
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
- (2017) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
- (2017) Frederick L. Locke et al. MOLECULAR THERAPY
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
- (2017) Azharuddin Sajid Syed Khaja et al. Oncotarget
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
- (2016) Amos Kirilovsky et al. INTERNATIONAL IMMUNOLOGY
- Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
- (2016) J. Galon et al. Journal of Translational Medicine
- Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma
- (2016) Ha Young Park et al. Oncotarget
- A Distinct Function of Regulatory T Cells in Tissue Protection
- (2015) Nicholas Arpaia et al. CELL
- Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy
- (2014) Antonino Carbone et al. ANNALS OF HEMATOLOGY
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP
- (2014) R. Coutinho et al. HAEMATOLOGICA
- The immune landscape of human tumors
- (2014) Gabriela Bindea et al. OncoImmunology
- Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
- (2013) Angelique W. Whitehurst Annual Review of Pharmacology and Toxicology
- Cyclophosphamide Induces a Type I Interferon-Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
- (2013) F. Moschella et al. CLINICAL CANCER RESEARCH
- From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
- (2013) Helen Angell et al. CURRENT OPINION IN IMMUNOLOGY
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
- (2013) Michael C. Jensen et al. IMMUNOLOGICAL REVIEWS
- Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma
- (2013) Tvrtko Hudolin et al. Journal of Translational Medicine
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
- (2008) Yoshiki Mizukami et al. INTERNATIONAL JOURNAL OF CANCER
- Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma
- (2008) Kai Fu et al. JOURNAL OF CLINICAL ONCOLOGY
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search